Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Sodium metabisulfite
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 29 studies.
2023–2026
Showing all 29 studies, sorted by most relevant.
Chenxing Du, Yizhong Shen, Xiyang Zhong, et al.
Food chemistry, 2024
- Carps
- Catechin
- Gels
S. Dänicke, L. Carlson, A. Heymann, et al.
Mycotoxin Research, 2023
- Fusarium
- Trichothecenes
- Zearalenone
Female pigs respond sensitive both to DON and ZEN with anorexia and endocrine disruption, respectively, when critical diet concentrations are exceeded. Therefore, the frequent co-contamination of feed by DON and ZEN requires their parallel inactivation. The additive ZenA hydrolyzes ZEN while SBS inactivates DON through sulfonation. Both supplements were simultaneously added (+, 2.5 g SBS and 100 U ZenA/kg) to a control diet (CON-, 0.04 mg DON and < 0.004 mg ZEN/kg; CON+, 0.03 mg DON and < 0.004 mg ZEN/kg) and a Fusarium toxin contaminated diet (FUS-, 2.57 mg DON and 0.24 mg ZEN/kg; FUS+, 2.04 mg DON and 0.24 mg ZEN/kg). The 4 diets were fed to 20 female weaned piglets each (6 kg initial body weight) for 35 days; the piglets were sacrificed thereafter for collecting samples. Supplements improved performance and modified metabolism and hematology independent of dietary DON contamination. The mechanisms behind these changes could not be clarified and require further consideration. SBS reduced DON concentration in feed by approximately 20% and to the same extent in blood plasma and urine suggesting that no further DON sulfonate formation occurred in the digestive tract before absorbing DON in the upper digestive tract or that additionally formed DON sulfonates escaped absorption. DON sulfonates were detected in feces suggesting that unabsorbed DON sulfonates reached feces and/or that unabsorbed DON was sulfonated in the hindgut. The observed reduction rate of 20% was evaluated to be insufficient for feeding practice. Galenic form of SBS added to dry feed needs to be improved to support the DON sulfonation in the proximal digestive tract.ZenA was active in the digestive tract as demonstrated by the presence of its hydrolyzed none-estrogenic reaction products hydrolyzed ZEN (HZEN) and decarboxylated and hydrolyzed ZEN (DHZEN) both in feces, systemic circulation, and urine of group FUS+ compared to group FUS-. The presence of these hydrolysis products was paralleled by a significant decrease in high-estrogenic ZEN concentrations which, in turn, was related to a decrease in relative weights of uteri and ovaries when compared to group FUS-. Thus, ZenA was proven to be effective; both in terms of biomarkers and biological effects.
Abstract licence: CC BY
Nancy Wairimu, P. Wairagu, Kennedy W. Chepukosi, et al.
Journal of Toxicology, 2023
Sodium metabisulfite (SMB) is a biocide and antioxidant agent generally used as a preservative in food and beverage industries but can oxidize to harmful sulfite radicals. A standardized Ginkgo biloba (EGb-761) has demonstrated potent antioxidant and anti-inflammatory activities, which is beneficial for the treatment of diseases that exhibit oxidative stress and inflammation. The present study sought to investigate the putative ameliorative effects of EGb-761 against SMB-induced toxicity in mice. Thirty-two male Swiss white mice were randomized into control, SMB-treated, SMB + EGb-761-treated, and EGb-761-treated groups. EGb-761 (100 mg/kg/day) and SMB (98 mg/kg/day) were administered by gastric gavage for 40 days. Oral administration of EGb-761 restored SMB-induced decrease in body weight and prevented SMB-induced thrombocytopenia, leukocytosis, and anemia. Furthermore, EGb-761-treatment protected against SMB-induced liver and kidney injury depicted by decreased serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, bilirubin, creatinine, urea, uric acid, and albumin. Furthermore, EGb-761 treatment attenuated SMB-driven dyslipidemia and metabolic acidosis. Besides, EGb-761 supplementation abrogated SMB-driven oxidative stress as depicted by stabilized reduced glutathione (GSH) levels in the brain, liver, kidney, spleen, heart, and lungs. SMB induced a significant increase of tissue levels of malondialdehyde (MDA), serum nitric oxide (NO), interferon-gamma (IFN-γ) and tumor necrosis factor-α (TNF-α) which were abrogated by EGb-761 treatment. In conclusion, these results deepen our understanding of EGb-761 in light of various detrimental effects of SMB-driven toxicities. These findings provide a novel approach that can be optimized for preventing or treating exposure due to SMB toxicity.
Abstract licence: CC BY
F. Hidayat, E. Indarti, N. Arahman, et al.
IOP Conference Series: Earth and Environmental Science, 2023
Abstract Starch can be produced from many plant varieties and through various processing methods. Breadnut ( Artocarpus camansi ) is a plant variety containing seeds that are rich in carbohydrates to produce starch. However, it has not been widely used and converted into useful products because it is still traditionally considered waste. Starch can be produced physically, chemically, and enzymatically. In this study, the starch extraction from breadnut seeds was conducted using a chemical method, namely immersion into sodium metabisulfite (Na 2 S 2 O 5 ) at concentrations of 600, 800, and 1000 ppm. Characterization includes starch content, water content, amylose content, crystallinity using XRD (X-Ray Diffraction), functional groups using FTIR (Fourier Transform Infrared Spectroscopy), and morphology using SEM (Scanning Electron Microscope). The results showed the immersion of breadnut seeds into sodium metabisulfite affected the physicochemical properties. The produced starch content ranged from 53.56-54.87%; water content ranged from 5.83-6.66%; amylose content ranged from 27.07-30.80%. Based on the X-ray diffraction pattern, breadnut seed starch belonged to Type B which reached the highest peak at 17° 2θ. The functional group also showed the same FTIR spectrum in the breadnut seeds starch. Meanwhile, the morphological result showed that the starch granules of breadnut seeds ranged from 6.6 μm to 8.1 μm.
Abstract licence: CC BY
G. Suyantara, H. Miki, D. Ochi, et al.
Advanced Powder Technology, 2023
Wei Xiao, Zhimei Tang, F. He, et al.
Advanced Synthesis & Catalysis, 2024
Xuyang Ren, Wanshan Yang, Huining Zhang, et al.
Food chemistry, 2024
- Bread
- Flour
- Plant Proteins
Pawan Kumar, Archana Rai, M. Nireekshan Kumar, et al.
The Journal of organic chemistry, 2023
Chenxing Du, Xuefei Yang, Chuyan Wang, et al.
LWT, 2023
This study aimed to investigate the influence of different concentrations of sodium metabisulfite on the conformation of the myofibrillar protein (MP) and its covalent complexation with (−)-epigallocatechin-3-gallate (EGCG). Changes in sodium dodecyl SDS‒PAGE and free thiol content indicated that disulfide bonds in MP were disrupted by sodium metabisulfite, resulting in a maximum 3.82-fold increase in free thiol concentration compared to the control group. Fluorescence spectra and circular dichroism analysis revealed that when sodium metabisulfite was added at a concentration of 1 mmol/L, hydrophobic forces drove the self-assembly of MP, leading to a reduction in particle size to 53.21 μm and an increase in β-sheet content to 11.27%. Upon complexation with EGCG, the structure of MP became looser, causing an increase in particle size to 169.01 μm and a significant decrease in α-helix content to a maximum of 39.46%. This study revealed that increasing the concentration of sodium metabisulfite promoted the covalent complexation of MP with EGCG, with the optimal complexation observed at 1 mmol/L sodium metabisulfite, resulting in a notable 97.1% free radical sca0venging activity (compared to 77.8 % in the control group). These findings provide an economical and effective method to alleviate limitations in the food industry regarding MP utilization.
Abstract licence: CC BY-NC-ND
J. Richter, Preston Watanabe, Joshua B Bernin, et al.
Journal of the science of food and agriculture, 2024
- Meat Substitutes
- Cysteine
- Food Handling
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Investigational
Major interactions
None known
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Sodium metabisulfite
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
Molecular structure

Linked open data from Wikidata (Q284549), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication. Molecular structure images from Wikimedia Commons.